BioGend Therapeutics Co., Ltd.’s (6733) Moving Averages Convergence Divergence (MACD) indicator is -0.91, suggesting BioGend Therapeutics Co., Ltd. is a Buy.
BioGend Therapeutics Co., Ltd.’s (6733) 20-Day exponential moving average is TWD 23.15, while BioGend Therapeutics Co., Ltd.’s (6733) share price is TWD 21.00, making it a Sell.
BioGend Therapeutics Co., Ltd.’s (6733) 50-Day exponential moving average is TWD 24.30, while BioGend Therapeutics Co., Ltd.’s (6733) share price is TWD 21.00, making it a Sell.
BioGend Therapeutics Co., Ltd.’s (6733) 10-Day exponential moving average is TWD 22.37, while BioGend Therapeutics Co., Ltd.’s (6733) share price is TWD 21.00, making it a Sell.
BioGend Therapeutics Co., Ltd.’s (6733) 100-Day exponential moving average is TWD 25.66, while BioGend Therapeutics Co., Ltd.’s (6733) share price is TWD 21.00, making it a Sell.
BioGend Therapeutics Co., Ltd.’s (6733) stock price is TWD 21.00 and BioGend Therapeutics Co., Ltd.’s (6733) 50-day simple moving average is TWD 24.79, creating a Sell signal.
BioGend Therapeutics Co., Ltd.’s (6733) stock price is TWD 21.00 and BioGend Therapeutics Co., Ltd.’s (6733) 100-day simple moving average is TWD 25.08, creating a Sell signal.
BioGend Therapeutics Co., Ltd.’s (6733) stock price is TWD 21.00 and BioGend Therapeutics Co., Ltd.’s (6733) 200-day simple moving average is TWD 28.89, creating a Sell signal.